1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Pediatric AML: new trials by email Literature Review of Pediatric AML trials Research Report on Pediatric AML
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Evaluating the Safety and Activity of Pegylated Recombinant Human Arginase (BCT-100) PEG- BCT-100 - Cancer, Pediatric Solid Tumor | Phase 1 / Phase 2 | Completed | University of Birmingham | 49 | 2018-08-28 | 2022-09-02 |
Neoplasms (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Leukemia (1) · Leukemia, Lymphoid (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1) · Neoplasms by Histologic Type (1)
BCT-100 (1)
Australia (1) · Netherlands (1) · United Kingdom (1)